Electronic Quality Management System (eQMS) for Medicines Discovery Catapult

Tender description

Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC requires a robust Electronic Quality Management System (eQMS) to support business growth and new projects involving clinical samples. The new eQMS is required to provide full traceability for all activities pertaining to clinical samples, whilst also supporting MDC’s operations at large. Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=532e9bbc-1846-ed11-811a-005056b64545&projectId=482d48e6-1046-ed11-811a-005056b64545 Lot 1: Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC requires a robust eQMS to support business growth and new projects involving clinical samples. The new eQMS is required to provide full traceability for all activities pertaining to clinical samples, whilst also supporting MDC’s operations at large. An open procurement procedure is being used. Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=532e9bbc-1846-ed11-811a-005056b64545&projectId=482d48e6-1046-ed11-811a-005056b64545